Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Milad Darou is an Iranian pharmaceutical company specializing in the development and production of high-tech and specialized medicines. The company focuses on therapeutic areas such as oncology, endocrinology, and cardiovascular diseases, producing both active pharmaceutical ingredients (APIs) and finished dosage forms. Milad Darou is known for its manufacturing capabilities in specialized formulations, including hormonal and anti-cancer drugs. They aim to provide affordable access to complex medications within the Iranian market and regional exports. The company operates under strict GMP standards to ensure the quality and safety of its pharmaceutical products. Their portfolio includes widely used treatments for breast cancer and thyroid disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Milad Darou.